# Methylene Blue in Severe Sepsis and Septic Shock

> **NCT01797978** · PHASE3 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 354 (estimated)

## Conditions studied

- Severe Sepsis
- Septic Shock

## Interventions

- **DRUG:** Intravenous methylene blue administration
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01797978
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2016-01
- **Final completion:** 2017-03
- **Target enrollment:** 354 (ESTIMATED)
- **Last updated:** 2015-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01797978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01797978, "Methylene Blue in Severe Sepsis and Septic Shock". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01797978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*